Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAVER-I: Intra-Arterial Verapamil for Acute Ischemic Stroke
NCT02235558Phase 1Completed
- Start
- Feb 2013
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of verapamil in ischemic stroke. Primary endpoint: Presence or absence of intracranial hemorrhage. Started Feb 2013; status: completed.
02
Drugs
verapamil
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02235558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02235558.